FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3620260> ?p ?o ?g. }

• W3620260 endingPage "1516" @default.
• W3620260 startingPage "1510" @default.
• W3620260 abstract "We aimed to evaluate the efficacy and safety of ranolazine in a larger and more diverse group of patients with angina than previously studied.Ranolazine is an antianginal shown to reduce angina and improve exercise performance in selected patients with early-positive exercise testing and those with frequent angina.We investigated the antianginal effects of ranolazine in the subgroup of patients with prior chronic angina (n = 3,565, 54%) enrolled in the randomized, double-blind, placebo-controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes) 36 trial of patients with acute coronary syndrome. Follow-up was a median of 350 days.Patients with prior angina received evidence-based therapy (95% aspirin, 78% statins, 89% beta-blockers, average 2.9 antianginal agents). The primary end point (cardiovascular death, myocardial infarction, recurrent ischemia) was less frequent with ranolazine (hazard ratio [HR]: 0.86; 95% confidence interval [CI]: 0.75 to 0.97; p = 0.017), due entirely to a significant reduction in recurrent ischemia (HR: 0.78; 95% CI: 0.67 to 0.91; p = 0.002). Ranolazine also reduced worsening angina (HR: 0.77; 95% CI: 0.59 to 1.00; p = 0.048) and intensification of antianginal therapy (HR: 0.77; 95% CI: 0.64 to 0.92, p = 0.005). Exercise duration at 8 months was greater with ranolazine (514 s vs. 482 s, p = 0.002). Cardiovascular death or myocardial infarction did not differ between treatment groups (HR: 0.97; 95% CI: 0.80 to 1.16; p = 0.71). Symptomatic documented arrhythmias (2.9% vs. 2.9%, p = 0.92) and total mortality (6.2% vs. 6.4%, p = 0.96) were similar with ranolazine or placebo.In this largest study of ranolazine in patients with established coronary artery disease, ranolazine was effective in reducing angina with favorable safety in a substantially broader group of patients with angina than previously studied. (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary Syndromes; NCT00099788)." @default.
• W3620260 created "2016-06-24" @default.
• W3620260 creator A5022267024 @default.
• W3620260 creator A5048789881 @default.
• W3620260 creator A5058503662 @default.
• W3620260 creator A5059441645 @default.
• W3620260 creator A5072408201 @default.
• W3620260 creator A5083594961 @default.
• W3620260 creator A5085897222 @default.
• W3620260 creator A5091842991 @default.
• W3620260 date "2009-04-01" @default.
• W3620260 modified "2023-09-30" @default.
• W3620260 title "Efficacy of Ranolazine in Patients With Chronic Angina" @default.
• W3620260 cites W1477089198 @default.
• W3620260 cites W2000059795 @default.
• W3620260 cites W2014750372 @default.
• W3620260 cites W2034690624 @default.
• W3620260 cites W2044387787 @default.
• W3620260 cites W2045377209 @default.
• W3620260 cites W2047563687 @default.
• W3620260 cites W2049390983 @default.
• W3620260 cites W2083069953 @default.
• W3620260 cites W2087388640 @default.
• W3620260 cites W2090376664 @default.
• W3620260 cites W2099873623 @default.
• W3620260 cites W2135491318 @default.
• W3620260 cites W2136221971 @default.
• W3620260 cites W2136525802 @default.
• W3620260 cites W2144126218 @default.
• W3620260 cites W2148346557 @default.
• W3620260 cites W2155598961 @default.
• W3620260 cites W2160414137 @default.
• W3620260 cites W4252057047 @default.
• W3620260 doi "https://doi.org/10.1016/j.jacc.2009.01.037" @default.
• W3620260 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19389561" @default.
• W3620260 hasPublicationYear "2009" @default.
• W3620260 type Work @default.
• W3620260 sameAs 3620260 @default.
• W3620260 citedByCount "158" @default.
• W3620260 countsByYear W36202602012 @default.
• W3620260 countsByYear W36202602013 @default.
• W3620260 countsByYear W36202602014 @default.
• W3620260 countsByYear W36202602015 @default.
• W3620260 countsByYear W36202602016 @default.
• W3620260 countsByYear W36202602017 @default.
• W3620260 countsByYear W36202602018 @default.
• W3620260 countsByYear W36202602019 @default.
• W3620260 countsByYear W36202602020 @default.
• W3620260 countsByYear W36202602021 @default.
• W3620260 countsByYear W36202602022 @default.
• W3620260 countsByYear W36202602023 @default.
• W3620260 crossrefType "journal-article" @default.
• W3620260 hasAuthorship W3620260A5022267024 @default.
• W3620260 hasAuthorship W3620260A5048789881 @default.
• W3620260 hasAuthorship W3620260A5058503662 @default.
• W3620260 hasAuthorship W3620260A5059441645 @default.
• W3620260 hasAuthorship W3620260A5072408201 @default.
• W3620260 hasAuthorship W3620260A5083594961 @default.
• W3620260 hasAuthorship W3620260A5085897222 @default.
• W3620260 hasAuthorship W3620260A5091842991 @default.
• W3620260 hasBestOaLocation W36202601 @default.
• W3620260 hasConcept C126322002 @default.
• W3620260 hasConcept C142724271 @default.
• W3620260 hasConcept C164705383 @default.
• W3620260 hasConcept C168563851 @default.
• W3620260 hasConcept C204787440 @default.
• W3620260 hasConcept C207103383 @default.
• W3620260 hasConcept C27081682 @default.
• W3620260 hasConcept C2777628954 @default.
• W3620260 hasConcept C2777698277 @default.
• W3620260 hasConcept C2777995511 @default.
• W3620260 hasConcept C2778425758 @default.
• W3620260 hasConcept C2779177932 @default.
• W3620260 hasConcept C2780400711 @default.
• W3620260 hasConcept C44249647 @default.
• W3620260 hasConcept C500558357 @default.
• W3620260 hasConcept C541997718 @default.
• W3620260 hasConcept C71924100 @default.
• W3620260 hasConceptScore W3620260C126322002 @default.
• W3620260 hasConceptScore W3620260C142724271 @default.
• W3620260 hasConceptScore W3620260C164705383 @default.
• W3620260 hasConceptScore W3620260C168563851 @default.
• W3620260 hasConceptScore W3620260C204787440 @default.
• W3620260 hasConceptScore W3620260C207103383 @default.
• W3620260 hasConceptScore W3620260C27081682 @default.
• W3620260 hasConceptScore W3620260C2777628954 @default.
• W3620260 hasConceptScore W3620260C2777698277 @default.
• W3620260 hasConceptScore W3620260C2777995511 @default.
• W3620260 hasConceptScore W3620260C2778425758 @default.
• W3620260 hasConceptScore W3620260C2779177932 @default.
• W3620260 hasConceptScore W3620260C2780400711 @default.
• W3620260 hasConceptScore W3620260C44249647 @default.
• W3620260 hasConceptScore W3620260C500558357 @default.
• W3620260 hasConceptScore W3620260C541997718 @default.
• W3620260 hasConceptScore W3620260C71924100 @default.
• W3620260 hasIssue "17" @default.
• W3620260 hasLocation W36202601 @default.
• W3620260 hasLocation W36202602 @default.

• next